Skip to Content
Merck
  • Decreased sialylation of IgA1 O-glycans associated with pneumococcal hemolytic uremic syndrome.

Decreased sialylation of IgA1 O-glycans associated with pneumococcal hemolytic uremic syndrome.

Pediatrics international : official journal of the Japan Pediatric Society (2013-12-18)
Hisaaki Aoki, Masashi Shiomi, Tae Ikeda, Tsubura Ishii, Nobuhiko Shimizu, Masao Togawa, Nobuhiko Okamoto, Machiko Kadoya, Yoshinao Wada
ABSTRACT

Hemolytic uremic syndrome (HUS) in children is usually caused by Shiga-like toxin-producing Escherichia coli, but approximately 5% of cases are caused by invasive pneumococcal infection (P-HUS). Reported herein is the case of a 9-month-old HUS patient with pneumococcal meningitis who needed hemodialysis for 12 days. Decreased sialylation was characterized in both transferrin N-glycans and IgA1 O-glycans, analyzed in the acute phase on mass spectrometry, consistent with S. pneumonia-produced sialidases hydrolyzing both α2,3- and α2,6-linked sialic acids. The method will complement the T-antigen activation test and help to understand the molecular pathology related to P-HUS.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
N-Acetyl-2,3-dehydro-2-deoxyneuraminic acid, ≥93% (TLC)